These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34472086)

  • 1. Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
    Hines PC; Callaghan MU; Zaidi AU; Gao X; Liu K; White J; Tarasev M
    Br J Haematol; 2021 Sep; 194(6):1074-1082. PubMed ID: 34472086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.
    White J; Callaghan MU; Gao X; Liu K; Zaidi A; Tarasev M; Hines PC
    Br J Haematol; 2022 Feb; 196(4):1052-1058. PubMed ID: 34850378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Al Najjar S; Adam S; Ahmed N; Qari M
    Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional analysis of adhesion in individuals with sickle cell disease using a standardized whole blood adhesion bioassay to VCAM-1.
    White J; Lancelot M; Gao X; McGraw BJ; Tabb C; Hines P
    Blood Cells Mol Dis; 2020 Mar; 81():102397. PubMed ID: 31864103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy.
    Kunz Mathews M; McLeod DS; Merges C; Cao J; Lutty GA
    Br J Ophthalmol; 2002 Jun; 86(6):684-90. PubMed ID: 12034693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Sickle Red Blood Cell Adhesion and its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative.
    Alshaiban A; Muralidharan-Chari V; Nepo A; Mousa SA
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):230-8. PubMed ID: 25601897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.
    Klings ES; Anton Bland D; Rosenman D; Princeton S; Odhiambo A; Li G; Bernard SA; Steinberg MH; Farber HW
    Am J Hematol; 2008 Jul; 83(7):547-53. PubMed ID: 18383329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.
    Hatzipantelis ES; Pana ZD; Gombakis N; Taparkou A; Tzimouli V; Kleta D; Zafeiriou DJ; Garipidou V; Kanakoudi F; Athanassiou M
    Int J Hematol; 2013 Aug; 98(2):158-63. PubMed ID: 23807289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VLA-4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow.
    White J; Krishnamoorthy S; Gupta D; Lancelot M; Moore N; Sarnaik S; Hobbs WE; Light DR; Hines P
    Br J Haematol; 2016 Sep; 174(6):970-82. PubMed ID: 27291690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment.
    Stuart MJ; Setty BN
    Blood; 1999 Sep; 94(5):1555-60. PubMed ID: 10477680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.
    Pittman DD; Hines PC; Beidler D; Rybin D; Frelinger AL; Michelson AD; Liu K; Gao X; White J; Zaidi AU; Charnigo RJ; Callaghan MU
    Blood; 2021 Apr; 137(15):2010-2020. PubMed ID: 33067606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion.
    Setty BN; Chen D; O'Neal P; Littrell JB; Grossman MH; Stuart MJ
    J Lab Clin Med; 1998 Apr; 131(4):344-53. PubMed ID: 9579388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment.
    Man Y; Goreke U; Kucukal E; Hill A; An R; Liu S; Bode A; Solis-Fuentes A; Nayak LV; Little JA; Gurkan UA
    Blood Cells Mol Dis; 2020 Jul; 83():102424. PubMed ID: 32208292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of Soluble Endothelium Adhesion Molecules and Complications among Sickle Cell Disease Patients in Ghana.
    Antwi-Boasiako C; Donkor ES; Sey F; Dzudzor B; Dankwah GB; Otu KH; Doku A; Dale CA; Ekem I
    Diseases; 2018 Apr; 6(2):. PubMed ID: 29690499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular adhesion and the endothelium: P-selectin.
    Kutlar A; Embury SH
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):323-39. PubMed ID: 24589269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells.
    Okpala I; Daniel Y; Haynes R; Odoemene D; Goldman J
    Eur J Haematol; 2002 Sep; 69(3):135-44. PubMed ID: 12406006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
    Coyne KS; Currie BM; Callaghan M; Wyrwich KW; Pease S; Baker CL; Arkin S; Pittman DD
    Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte adhesion and the pathophysiology of sickle cell disease.
    Okpala I
    Curr Opin Hematol; 2006 Jan; 13(1):40-4. PubMed ID: 16319686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin.
    Pierangeli SS; Espinola RG; Liu X; Harris EN
    Circ Res; 2001 Feb; 88(2):245-50. PubMed ID: 11157679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.